Genprex Inc is a biotechnology company focused on developing innovative gene therapy treatments for cancer and diabetes. Their primary aim is to enhance the efficacy of existing therapies and improve patient outcomes through the use of their proprietary Oncoprex immunogene therapy, which targets various types of tumors. The company is dedicated to advancing its promising treatments through clinical trials and aims to address significant unmet medical needs in oncology. With a strong emphasis on research and development, Genprex seeks to create transformative therapies that can benefit patients and improve their quality of life. Read More
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
The Outbreak: In 2025, the FDA confirmed 134 cases of Salmonella Enteritidis across 10 states, including 38 hospitalizations and one death, traced to August Egg Company’s brown cage-free and organic eggs. Environmental testing revealed the outbreak strain within the company’s laying houses—evidence that contamination originated at the production level, not in downstream distribution or retail.
NEW YORK, NY / ACCESS Newswire / September 30, 2025 / Investor Summit Group is pleased to announce that presentations from the Q3 Virtual Investor Summit are now accessible for on-demand viewing. Investors and attendees who were unable to join the live event can now explore company updates and insights at their convenience.
